Anavex Life Sciences (AVXL) Enterprise Value (2010 - 2025)
Anavex Life Sciences recorded quarterly Enterprise Value of -$131.7 million in Q4 2025, down 28.44% quarter-over-quarter from -$102.6 million in Q3 2025, and down 9.09% year-over-year from -$144.9 million in Q4 2024.
Anavex Life Sciences' Enterprise Value history runs 16 years deep, the most recent figure standing at -$131.7 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 9.09% year-over-year to -$131.7 million; the TTM figure through Dec 2025 stood at -$131.7 million (down 9.09% YoY), while the FY2025 annual figure was -$102.6 million, up 22.4% from the prior year.
- Enterprise Value came in at -$131.7 million for Q4 2025 at Anavex Life Sciences, down from -$102.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$75.9 million in Q1 2021 to a low of -$157.6 million in Q2 2021.
- A 5-year average of -$136.1 million and a median of -$143.7 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 470.47% in 2021 and advanced 27.09% in 2025, its largest moves.
- Anavex Life Sciences' Enterprise Value stood at -$151.1 million in 2021, then grew by 4.98% to -$143.6 million in 2022, then declined by 0.1% to -$143.8 million in 2023, then climbed by 15.99% to -$120.8 million in 2024, then dropped by 9.09% to -$131.7 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$131.7 million, -$102.6 million, and -$101.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | -131.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -131.75 Mn |
| Sep 30, 2025 | -102.58 Mn |
| Jun 30, 2025 | -101.16 Mn |
| Mar 31, 2025 | -115.77 Mn |
| Dec 31, 2024 | -120.78 Mn |
| Sep 30, 2024 | -132.19 Mn |
| Jun 30, 2024 | -138.76 Mn |
| Mar 31, 2024 | -139.39 Mn |
| Dec 31, 2023 | -143.77 Mn |
| Sep 30, 2023 | -151.02 Mn |
| Jun 30, 2023 | -154.82 Mn |
| Mar 31, 2023 | -153.47 Mn |
| Dec 31, 2022 | -143.62 Mn |
| Sep 30, 2022 | -149.16 Mn |
| Jun 30, 2022 | -153.20 Mn |
| Mar 31, 2022 | -153.34 Mn |
| Dec 31, 2021 | -151.15 Mn |
| Sep 30, 2021 | -152.11 Mn |
| Jun 30, 2021 | -157.56 Mn |
| Mar 31, 2021 | -75.86 Mn |
| Dec 31, 2020 | -47.36 Mn |
| Sep 30, 2020 | -29.25 Mn |
| Jun 30, 2020 | -27.62 Mn |
| Mar 31, 2020 | -26.56 Mn |
| Dec 31, 2019 | -27.46 Mn |
| Sep 30, 2019 | -22.19 Mn |
| Jun 30, 2019 | -21.26 Mn |
| Mar 31, 2019 | -19.47 Mn |
| Dec 31, 2018 | -20.76 Mn |
| Sep 30, 2018 | -22.93 Mn |
| Jun 30, 2018 | -25.83 Mn |
| Mar 31, 2018 | -25.66 Mn |
| Dec 31, 2017 | -28.05 Mn |
| Sep 30, 2017 | -27.44 Mn |
| Jun 30, 2017 | -24.79 Mn |
| Mar 31, 2017 | -23.35 Mn |
| Dec 31, 2016 | -21.16 Mn |
| Sep 30, 2016 | -9.19 Mn |
| Jun 30, 2016 | -9.73 Mn |
| Sep 30, 2015 | -15.29 Mn |
| Jun 30, 2015 | -7.96 Mn |
| Mar 31, 2015 | -6.31 Mn |
| Dec 31, 2014 | -6.98 Mn |
| Sep 30, 2014 | -7.26 Mn |
| Jun 30, 2014 | -8.18 Mn |
| Mar 31, 2014 | -9.19 Mn |
| Dec 31, 2013 | -95,927.00 |
| Sep 30, 2013 | -345,074.00 |
| Jun 30, 2013 | -1,645.00 |
| Mar 31, 2013 | -487.00 |
| Dec 31, 2012 | -79,789.00 |
| Sep 30, 2012 | -11,362.00 |
| Jun 30, 2012 | -18,195.00 |
| Mar 31, 2012 | -178,647.00 |
| Dec 31, 2011 | -9,079.00 |
| Sep 30, 2011 | -134,702.00 |
| Jun 30, 2011 | -1.22 Mn |
| Mar 31, 2011 | -3,641.00 |
| Sep 30, 2010 | -264,669.00 |